0.10
+0.0121(+13.44%)
Currency In USD
| Previous Close | 0.09 |
| Open | 0.09 |
| Day High | 0.11 |
| Day Low | 0.09 |
| 52-Week High | 206 |
| 52-Week Low | 0.05 |
| Volume | 129,316 |
| Average Volume | 2.55M |
| Market Cap | 123,067 |
| PE | -0.01 |
| EPS | -7.35 |
| Moving Average 50 Days | 1.32 |
| Moving Average 200 Days | 9.19 |
| Change | 0.01 |
If you invested $1000 in CERo Therapeutics Holdings, Inc. (CERO) since IPO date, it would be worth $0.01 as of December 14, 2025 at a share price of $0.102. Whereas If you bought $1000 worth of CERo Therapeutics Holdings, Inc. (CERO) shares 3 years ago, it would be worth $0 as of December 14, 2025 at a share price of $0.102.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CERo Therapeutics Announces Trading on OTCQB Market
GlobeNewswire Inc.
Dec 02, 2025 12:30 PM GMT
Company’s Shares Will Continue to Trade Under Ticker CERO SOUTH SAN FRANCISCO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (OTCQB : CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company develo
CERo Therapeutics Initiates Second Cohort of Phase 1 Clinical Trial of CER-1236 in AML with Patient Receiving Significant Increase in Dosing
GlobeNewswire Inc.
Nov 05, 2025 1:00 PM GMT
SOUTH SAN FRANCISCO, Calif, Nov. 05, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (OTC PINK: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanisms, announce
CERo Therapeutics to Present Data at the Society for Immunotherapy of Cancer Conference Highlighting Lead Compound CER-1236 Sustained Cell Expansion and Cytokine Response
GlobeNewswire Inc.
Nov 04, 2025 2:05 PM GMT
Newly released preclinical data to be presented in a poster on November 8, 2025 SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (OTC PINK: CERO) (“CERo” or the “Company”), an innovative cellular immu